Matches in Wikidata for { <http://www.wikidata.org/entity/Q86675111> ?p ?o ?g. }
Showing items 1 to 46 of
46
with 100 items per page.
- Q86675111 description "article scientifique publié en 2015" @default.
- Q86675111 description "artículu científicu espublizáu en xineru de 2015" @default.
- Q86675111 description "scientific article published on 29 January 2015" @default.
- Q86675111 description "wetenschappelijk artikel" @default.
- Q86675111 description "наукова стаття, опублікована в січні 2015" @default.
- Q86675111 name "Secondary antibody-induced treatment failure under therapy with incobotulinumtoxinA (Xeomin®) in a patient with segmental dystonia pretreated with abobotulinumtoxinA (Dysport®)" @default.
- Q86675111 name "Secondary antibody-induced treatment failure under therapy with incobotulinumtoxinA (Xeomin®) in a patient with segmental dystonia pretreated with abobotulinumtoxinA (Dysport®)" @default.
- Q86675111 type Item @default.
- Q86675111 label "Secondary antibody-induced treatment failure under therapy with incobotulinumtoxinA (Xeomin®) in a patient with segmental dystonia pretreated with abobotulinumtoxinA (Dysport®)" @default.
- Q86675111 label "Secondary antibody-induced treatment failure under therapy with incobotulinumtoxinA (Xeomin®) in a patient with segmental dystonia pretreated with abobotulinumtoxinA (Dysport®)" @default.
- Q86675111 prefLabel "Secondary antibody-induced treatment failure under therapy with incobotulinumtoxinA (Xeomin®) in a patient with segmental dystonia pretreated with abobotulinumtoxinA (Dysport®)" @default.
- Q86675111 prefLabel "Secondary antibody-induced treatment failure under therapy with incobotulinumtoxinA (Xeomin®) in a patient with segmental dystonia pretreated with abobotulinumtoxinA (Dysport®)" @default.
- Q86675111 P1104 Q86675111-266FA60A-74F7-451F-A22D-B9A8C10F00C8 @default.
- Q86675111 P1433 Q86675111-5158B2C1-C19E-4DB2-AE17-D725E1FA0EE3 @default.
- Q86675111 P1476 Q86675111-1F88E822-95F2-4A76-BCA3-CB22569074E5 @default.
- Q86675111 P2093 Q86675111-0919164F-AF7B-4664-9A6B-073479FD8515 @default.
- Q86675111 P2093 Q86675111-1B69DE01-B43E-4201-AC19-6042C34D3BDA @default.
- Q86675111 P2093 Q86675111-AD7E4FC8-2E84-4137-A520-996358D2032C @default.
- Q86675111 P2093 Q86675111-EA461835-C923-4CC9-814B-4AFE95712339 @default.
- Q86675111 P304 Q86675111-E825F217-04DF-4A66-BA53-90256EF0AE2C @default.
- Q86675111 P31 Q86675111-D22D1535-43A4-4BC1-B88F-3E98EDC0885D @default.
- Q86675111 P356 Q86675111-E7B4A201-56C8-48A3-B305-01265DEC0529 @default.
- Q86675111 P433 Q86675111-A2F53D5D-62A8-49FF-B042-D25DDFEEC0C8 @default.
- Q86675111 P478 Q86675111-D7370DE3-FD3F-4C37-8D8F-5EC628B35F0D @default.
- Q86675111 P577 Q86675111-FF3C713A-0A9C-41BB-BFBE-5C6327510158 @default.
- Q86675111 P698 Q86675111-91062E4D-AB64-4D72-8FA2-614A873FD7FB @default.
- Q86675111 P921 Q86675111-38526ADA-A293-40B5-97FD-CE5B88D4B022 @default.
- Q86675111 P921 Q86675111-98FF71FD-E2B2-442D-B30D-58089953B63A @default.
- Q86675111 P356 J.JNS.2015.01.032 @default.
- Q86675111 P698 25656102 @default.
- Q86675111 P1104 "+2" @default.
- Q86675111 P1433 Q6296168 @default.
- Q86675111 P1476 "Secondary antibody-induced treatment failure under therapy with incobotulinumtoxinA (Xeomin®) in a patient with segmental dystonia pretreated with abobotulinumtoxinA (Dysport®)" @default.
- Q86675111 P2093 "Christoph Kamm" @default.
- Q86675111 P2093 "Eilhard Mix" @default.
- Q86675111 P2093 "Friederike Schümann" @default.
- Q86675111 P2093 "Reiner Benecke" @default.
- Q86675111 P304 "110-111" @default.
- Q86675111 P31 Q13442814 @default.
- Q86675111 P356 "10.1016/J.JNS.2015.01.032" @default.
- Q86675111 P433 "1-2" @default.
- Q86675111 P478 "350" @default.
- Q86675111 P577 "2015-01-29T00:00:00Z" @default.
- Q86675111 P698 "25656102" @default.
- Q86675111 P921 Q18553507 @default.
- Q86675111 P921 Q4095199 @default.